Myocardial preservation specific for cardiomyocytes
心肌细胞特异性心肌保存
基本信息
- 批准号:16591420
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Objective : Dystrophin is a membrane protein that protects the sarcolemma from oncosis induced by physical stress. Because ischemic preconditioning (IPC) protects mitochondria and prevents oncosis during reperfusion, we hypothesized that dystrophin is a target of IPC distal to mitochondrial protection. Methods and Results : The isolated rat hearts were subjected to 30 minutes ischemia followed by reperfusion. IPC was introduced by 3 cycles of 5 minutes ischemia and 5 minutes reperfusion. The loss of sarcolemmal dystrophin and myocardial ATP during ischemia was similar in the control and the IPC heart. Similar loss of sarcolemmal dystrophin and myocardial ATP was observed when the heart was treated with 2,4-dinitrophenol (DNP), an uncoupler of mitochondrial respiration, or oligomycin, an inhibitor of mitochondrial F_1F_0-ATPase. However, the IPC heart increased sarcolemmal dystrophin during reperfusion associated with an increase in tetramethylrhodamine ethylester (TMRE) uptake, an indicator of mitochondrial membrane potential (Δψm), and myocardial ATP and inhibition of myocyte oncosis. The increase in relocalization of sarcolemmal dystrophin and myocardial ATP mediated by IPC was inhibited by treatment with DNP or oligomycin during reperfusion. Moreover, the ischemic IPC heart mitochondria increased relocalization of dystrophin from the insoluble to the soluble fractions associated with increased ATP generation in vitro in a DNP and oligomycin-sensitive manner. Conclusions : These results suggest that enhanced relocalization of dystrophin to the sarcolemma during reperfusion may be a mechanistic link between IPC-mediated improvement of mitochondrial function and its protection against oncosis upon reperfusion.
目的:肌营养不良蛋白(Dystrophin,Dystrophin)是一种保护肌膜免受物理应激引起的细胞胀亡的膜蛋白。由于缺血预处理(IPC)在再灌注期间保护线粒体并防止胀亡,我们假设肌营养不良蛋白是IPC的线粒体保护远端的靶点。方法和结果:采用离体大鼠心脏缺血30分钟再灌注模型。通过3个循环的5 min缺血和5 min再灌注引入IPC。心肌肌膜抗肌萎缩蛋白和心肌ATP在缺血期间的损失在对照组和IPC心脏中是相似的。用线粒体呼吸解偶联剂2,4-二硝基苯酚(DNP)或线粒体F_1F_0-ATP酶抑制剂寡霉素处理心肌,也观察到类似的肌膜抗肌萎缩蛋白和心肌ATP的丢失。然而,IPC心脏在再灌注期间增加了肌膜肌营养不良蛋白,与四甲基罗丹明乙酯(TMRE)摄取增加(线粒体膜电位(Δ Km)的指标)和心肌ATP和抑制肌细胞胀亡有关。DNP或寡霉素可抑制IPC介导的肌膜抗肌萎缩蛋白和心肌ATP的再定位。此外,缺血性IPC心脏线粒体增加肌营养不良蛋白从不溶性到可溶性部分的再定位,与体外增加的ATP生成相关,以DNP和寡霉素敏感的方式。结论:这些结果表明,增强再灌注过程中肌营养不良蛋白的肌膜重新定位可能是IPC介导的线粒体功能的改善和再灌注后对胀亡的保护之间的机制联系。
项目成果
期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Temporary blockade of contractility during reperfusion elicits a cardioprotective effect of the p38 MAP kinase inhibitor SB-203580
- DOI:10.1152/ajpheart.01183.2004
- 发表时间:2005-06-01
- 期刊:
- 影响因子:4.8
- 作者:Sumida, T;Otani, H;Imamura, H
- 通讯作者:Imamura, H
Integrated pharmacological preconditioning and Memory of cardioprotection : the role of protein kinase C and phosphatidylinositol 3-kinase.
综合药理学预处理和心脏保护记忆:蛋白激酶 C 和磷脂酰肌醇 3-激酶的作用。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Okada T;Otani H;Wu Y;Uchiyama T;Kyoi S;Hattori R;Sumide T;Fujiwara H;Imamura H.
- 通讯作者:Imamura H.
Ischemic preconditioning-mediated restoration of membrane dystrophin during reperfusion correlates with protection against contraction-induced myocardial injury
- DOI:10.1152/ajpheart.01140.2003
- 发表时间:2004-07-01
- 期刊:
- 影响因子:4.8
- 作者:Kido, M;Otani, H;Imamura, H
- 通讯作者:Imamura, H
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OTANI Hajime其他文献
OTANI Hajime的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OTANI Hajime', 18)}}的其他基金
Myocardial regeneration by targeting to microRNA
通过靶向 microRNA 实现心肌再生
- 批准号:
23591070 - 财政年份:2011
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies on anti-allergic properties of a mixture of Saccaromyces pastorianus and its specific cow's milk antibody
巴斯德酵母混合物及其特异性牛奶抗体抗过敏特性的研究
- 批准号:
22580306 - 财政年份:2010
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of active immunomodulatory function of milk IgG and development of its utility
牛奶 IgG 主动免疫调节功能的阐明及其应用的开发
- 批准号:
19580307 - 财政年份:2007
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of dystrophin in the pathogenesis of myocardial reperfusion injury
肌营养不良蛋白在心肌再灌注损伤发病机制中的作用
- 批准号:
19590838 - 财政年份:2007
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of non-allergic peptide preparation having mucosal immunostimulatory ability
具有粘膜免疫刺激能力的非过敏性肽制剂的研制
- 批准号:
13660266 - 财政年份:2001
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Mechanism of Tolerance against Hypothermia and Ischemia in Hibernators
冬眠者耐低温和缺血的机制
- 批准号:
12671335 - 财政年份:2000
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Myocardial protection during heart surgery by IGF-1 and bcl-2 gene introduction.
通过引入 IGF-1 和 bcl-2 基因来保护心脏手术期间的心肌。
- 批准号:
10671275 - 财政年份:1998
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of immnoregulating function of casein phosphopeptide
酪蛋白磷酸肽免疫调节功能的阐明
- 批准号:
10660258 - 财政年份:1998
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Na^+/H^+ Exchange Plays a Role in Hypoxia-Reoxygenation induced ICAM-1 expression in CME
Na^ /H^ 交换在 CME 缺氧-复氧诱导的 ICAM-1 表达中发挥作用
- 批准号:
08671551 - 财政年份:1996
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Immunosuppresive action of milk k-casein and its digests
牛奶酪蛋白及其消化物的免疫抑制作用
- 批准号:
08660328 - 财政年份:1996
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
e-Heart仿真平台及关键技术研究
- 批准号:60571025
- 批准年份:2005
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Operating Grants
Zinc Protection Against Ischemia-Reperfusion Injury in Heart
锌可预防心脏缺血再灌注损伤
- 批准号:
10652915 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Myocardial Vulnerability to Ischemia-Induced Dysfunction and Heart Failure: The Impact of HIV/SIV, ART, and Targeted Immunotherapy
心肌对缺血引起的功能障碍和心力衰竭的脆弱性:HIV/SIV、ART 和靶向免疫治疗的影响
- 批准号:
10426282 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别:
Myocardial Vulnerability to Ischemia-Induced Dysfunction and Heart Failure: The Impact of HIV/SIV, ART, and Targeted Immunotherapy
心肌对缺血引起的功能障碍和心力衰竭的脆弱性:HIV/SIV、ART 和靶向免疫治疗的影响
- 批准号:
10082623 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别:
Mitochondrial regulation of the NLRP3 inflammasome in myocardial ischemia-reperfusion injury and heart transplantation
NLRP3炎症小体在心肌缺血再灌注损伤和心脏移植中的线粒体调控
- 批准号:
10306406 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别:
Myocardial Vulnerability to Ischemia-Induced Dysfunction and Heart Failure: The Impact of HIV/SIV, ART, and Targeted Immunotherapy
心肌对缺血引起的功能障碍和心力衰竭的脆弱性:HIV/SIV、ART 和靶向免疫治疗的影响
- 批准号:
10643712 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别:
The protective effect of interleukin-11 on donor heart with warm ischemia
白细胞介素11对热缺血供心的保护作用
- 批准号:
20K17708 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of mechanism of ischemia-reperfusion injury using heart-, brain-, and kidney-on-a-chips
使用心脏、大脑和肾脏芯片阐明缺血再灌注损伤的机制
- 批准号:
20H04518 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitochondrial regulation of the NLRP3 inflammasome in myocardial ischemia-reperfusion injury and heart transplantation
NLRP3炎症小体在心肌缺血再灌注损伤和心脏移植中的线粒体调控
- 批准号:
10133482 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别:
Myocardial Vulnerability to Ischemia-Induced Dysfunction and Heart Failure: The Impact of HIV/SIV, ART, and Targeted Immunotherapy
心肌对缺血引起的功能障碍和心力衰竭的脆弱性:HIV/SIV、ART 和靶向免疫治疗的影响
- 批准号:
10226336 - 财政年份:2020
- 资助金额:
$ 2.24万 - 项目类别: